(Q34569440)

3 August 2017

1 reference

title

Molecular biology of lung cancer: clinical implications. (English)

1 reference

3 August 2017

0 references

Kwun M Fong

1

1 reference

PubMed ID

11901922

3 August 2017

John D Minna

series ordinal

2

1 reference

3 August 2017

1 March 2002

1 reference

Clinics in Chest Medicine

3 August 2017

1 reference

3 August 2017

23

1 reference

3 August 2017

1

1 reference

3 August 2017

83-101

1 reference

Microsatellite instability in primary and metastatic lung carcinomas

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Is there a genetic basis for lung cancer susceptibility?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Expression of human telomerase subunit genes in primary lung cancer and its clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Genetic polymorphisms in DNA repair genes and risk of lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Microsatellite alterations in plasma DNA of small cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Molecular biologic substaging of stage I lung cancer according to gender and histology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Bombesin receptor structure and expression in human lung carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Mutation analysis of the PTEN/MMAC1 gene in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Mechanisms of p16INK4A inactivation in non small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Early Lung Cancer Action Project: overall design and findings from baseline screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Telomerase activity in small-cell and non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Expression of bcl-2--protein in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Genetic instabilities in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Fine deletion mapping of chromosome 8p in non-small-cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Identification of novel regions of altered DNA copy number in small cell lung tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Serum p53 antibodies as early markers of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Clonal genetic alterations in the lungs of current and former smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

p53 mutations predict non-small cell lung carcinoma response to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

The role of pRb2/p130 protein in diagnosing lung carcinoma on fine needle aspiration biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

A novel molecular staging protocol for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Vascular endothelial growth factor and lymph node metastasis in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Deletion mapping of chromosome 2 in human lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Protein expression and functional analysis of the FHIT gene in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Immunocytochemical markers in stage I lung cancer: relevance to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

bcl-2 protein in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Insulin-like growth factor expression in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Gene replacement strategies for treating non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Non-ocular cancer in relatives of retinoblastoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Increased cancer risk among relatives of nonsmoking lung cancer cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Segregation analysis of smoking-associated malignancies: evidence for Mendelian inheritance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Microsatellite DNA instability in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

TP53 gene mutations in plasma DNA of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Mass screening for lung cancer with mobile spiral computed tomography scanner

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

The FHIT gene 3p14.2 is abnormal in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

The molecular epidemiology of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Bombesin-like peptides and airway repair: a recapitulation of lung development?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

p53: a frequent target for genetic abnormalities in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Immunohistochemical detection of basic fibroblast growth factor as a prognostic indicator in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Advances in the analysis of chromosome alterations in human lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Abnormal FHIT transcripts found in both lung cancer and normal lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Familial aggregation of lung cancer among hospital patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Alterations of the PPP2R1B gene in human lung and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Molecular damage in the bronchial epithelium of current and former smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Metabolic polymorphisms in carcinogen metabolising enzymes and cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Mutational analysis of p73 and p53 in human cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900062-5

7 January 2021

10.1016/S0272-5231(03)00062-5

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11901922